Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-20-000012
Filing Date
2020-03-06
Accepted
2020-03-06 15:38:02
Documents
119
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F oncyf2019-20f.htm 20-F 1831204
2 EXHIBIT 2.1 ex21exhibitdescriptionofse.htm EX-2.1 3969
3 EXHIBIT 4.1 ex41august2013hagerman.htm EX-4.1 69264
4 EXHIBIT 4.2 ex42hagermandec2015.htm EX-4.2 14863
5 EXHIBIT 4.3 ex43moorejan2017.htm EX-4.3 88849
6 EXHIBIT 4.6 ex46november2018laeufle.htm EX-4.6 282686
7 EXHIBIT 4.7 ex47hagermanamendment2019.htm EX-4.7 16919
8 EXHIBIT 4.8 ex48kirklook2019.htm EX-4.8 79378
9 EXHIBIT 4.9 ex49coffey2019.htm EX-4.9 77723
10 EXHIBIT 4.10 ex410guttadauroamendment20.htm EX-4.10 18318
11 EXHIBIT 4.11 ex411mooreamendment2020.htm EX-4.11 18471
12 EXHIBIT 4.12 ex412lauefleamendment2020.htm EX-4.12 16072
13 EXHIBIT 4.13 ex413hagermanamendment2020.htm EX-4.13 16357
14 EXHIBIT 4.14 ex414lookamendment2020.htm EX-4.14 16270
15 EXHIBIT 4.15 ex415coffeyamendment2020.htm EX-4.15 16277
16 EXHIBIT 8.0 ex80subsidiaries2019.htm EX-8.0 3935
17 EXHIBIT 12.1 ex121ceocertfication2019.htm EX-12.1 13555
18 EXHIBIT 12.2 ex122cfocertification2019.htm EX-12.2 12656
19 EXHIBIT 13.1 ex131ceocertification2019.htm EX-13.1 7109
20 EXHIBIT 13.2 ex132cfocertification2019.htm EX-13.2 5939
21 EXHIBIT 15.1 ex151-2019mda.htm EX-15.1 462456
22 EXHIBIT 15.2 ex152eyconsentletter2019.htm EX-15.2 5412
29 eysignaturea25.jpg GRAPHIC 6517
30 oncolyticslogotaglinebluea05.jpg GRAPHIC 367326
31 pelareorep-lga02.jpg GRAPHIC 460603
32 reolysinmoapanel4smalla02.jpg GRAPHIC 148102
  Complete submission text file 0001129928-20-000012.txt   10764050

Data Files

Seq Description Document Type Size
23 XBRL INSTANCE DOCUMENT oncyf-20191231.xml EX-101.INS 1668274
24 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncyf-20191231.xsd EX-101.SCH 77075
25 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncyf-20191231_cal.xml EX-101.CAL 72493
26 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncyf-20191231_def.xml EX-101.DEF 276416
27 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncyf-20191231_lab.xml EX-101.LAB 697967
28 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncyf-20191231_pre.xml EX-101.PRE 447832
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38512 | Film No.: 20694424
SIC: 2834 Pharmaceutical Preparations